Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.50
+0.18 (3.38%)
At close: Apr 17, 2025, 4:00 PM
5.49
-0.01 (-0.18%)
After-hours: Apr 17, 2025, 7:27 PM EDT
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 800 employees as of December 31, 2024. The number of employees increased by 300 or 60.00% compared to the previous year.
Employees
800
Change (1Y)
300
Growth (1Y)
60.00%
Revenue / Employee
$73,549
Profits / Employee
-$579,576
Market Cap
2.21B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
RXRX News
- 3 days ago - HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data - PRNewsWire
- 10 days ago - Recursion and Enamine Release New AI-Enabled Targeted Compound Libraries - GlobeNewsWire
- 18 days ago - Recursion to Participate in Upcoming Investor Conference - GlobeNewsWire
- 6 weeks ago - Recursion Pharmaceuticals' Update Could Shed Light On Pipeline, Cost-Saving Plans, Analyst Says - Benzinga
- 7 weeks ago - Recursion Pharmaceuticals, Inc. (RXRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Recursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th - GlobeNewsWire
- 2 months ago - Altitude Lab Startups Raise $154M in Capital - GlobeNewsWire